维普中文期刊产品整合服务
14篇 您的检索式:作者名="Falandry C"
    题名 作者 年代 出处 被引量
1Revisiting the frontiers of phar- macogenomics of colon cancer 显示文摘Falandry C Bonnefoy M Freyer G 2011Pharmacogenomics2011,12,9:1
2Celecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast cancer patients:a double-blind phaseⅢGINECO study显示文摘Falandry C Debled M Bachelot T 2009Breast Cancer Res Treat2009,116,3:1
3Celecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast cancer patients:a double-blind phase Ⅲ GINECO study显示文摘Falandry C Debled M Bachelot T 2009Breast Cancer Res Treat2009,116,3:1
4Biology of cancer and aging: a complex association with cellular senescence 显示文摘Falandry C Bonnefoy M Freyer G 2014J Clin Oncol2014,32,24:1
5Are aging biomarkers clini- cally relevant in oncogeriatrics 显示文摘Falandry C Gilson E Rudolph K L 2013Crit Rev Oncol Hematol2013,85,:1
6Celecoxib and exemestane versus placebo and exemestane in postmenopausalmetastatic breast cancer patients: a double-blind phase Ⅲ gineco study显示文摘Falandry C Debled M Bachelot T 2009Breast Cancer Res Treat2009,116,3:1
7CLLD8/KMT1F is a lysine methyhransferase that is important for chromosome segaega- tion显示文摘Falandry C Fourel G Galy V 2010J Biol Chem2010,285,20:1
8Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer 显示文摘Falandry C Canney PA Freyer G 2009Ann Oncol2009,20,4:1
9Celecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast cancer patients: a double-blind phase III GINECO study 显示文摘Falandry C Debled M Bachelot T 2009Breast Cancer Res Treat2009,116,3:1
10Trends in G-CSF use in 990 patients after EORTC and ASCO guidelines显示文摘FALANDRY C CAMPONE M CARTRON G 2010EurJ Cancer2010,46,13:1
11Role of com-bination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer显示文摘Falandry C Canney PA Freyer G 0,,04:1
12Biology of cancer and aging: a complex association with cellular senescence 显示文摘Falandry C Bonnefoy M Freyer G 2014J Clin Oncol2014,32,24:1
13Role of combination therapy with aromatase and cyclooxygenase -2 inbibitors in patients with metastatic breast cancer 显示文摘Falandry C Canney PA Freyer G 2009Ann Oncol2009,20,4:1
14C elecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast canser patients:a double-blind phase GINECO study显示文摘Falandry C Deb led M Bachelot T 2009Breast Cancer Res Treat2009,116,3:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费